sur Lir Life Sciences Corp. (CVE:SKNY)
LIR Life Sciences Appoints Dr. Peter Singer as Scientific Advisor
LIR Life Sciences Corp. has announced the appointment of Dr. Peter Singer as a Scientific Advisor. Dr. Singer is recognized for his expertise in global health, having previously served as Special Advisor to the Director General of the World Health Organization. He brings over 25 years of leadership in health innovation and policy.
Dr. Singer's past roles include CEO of Grand Challenges Canada, where he managed over CAD $450 million in funding for health innovations worldwide. His academic accomplishments include serving as Professor of Medicine Emeritus at the University of Toronto.
At LIR, Dr. Singer will contribute to strategies for expanding obesity treatment access globally. His deep understanding of health systems and policy is expected to support LIR in offering scalable, practical solutions to the obesity epidemic.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Lir Life Sciences Corp.